Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/12483
Title: Peripheral α-defensins 1 and 2 are elevated in Alzheimer's disease.
Austin Authors: Watt, Andrew D;Perez, Keyla A;Ang, Ching-Seng;O'Donnell, Paul;Rembach, Alan;Pertile, Kelly K;Rumble, Rebecca L;Trounson, Brett O;Fowler, Christopher J;Faux, Noel G;Masters, Colin L ;Villemagne, Victor L ;Barnham, Kevin J
Affiliation: The Florey Institute of Neuroscience and Mental Health, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Melbourne, Victoria, Australia The Neuroproteomics Platform, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Melbourne, Victoria, Australia
The Florey Institute of Neuroscience and Mental Health, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Melbourne, Victoria, Australia
The Florey Institute of Neuroscience and Mental Health, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Melbourne, Victoria, Australia Department of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, Victoria, Australia
Mass Spectrometry and Proteomics Facility, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Melbourne, Victoria, Australia
The Florey Institute of Neuroscience and Mental Health, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Melbourne, Victoria, Australia Department of Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Melbourne, Victoria, Australia The Neuroproteomics Platform, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Melbourne, Victoria, Australia
Issue Date: 2015
Publication information: Journal of Alzheimer's Disease : Jad; 44(4): 1131-43
Abstract: Biomarkers enabling the preclinical identification of Alzheimer's disease (AD) remain one of the major unmet challenges in the field. The blood cellular fractions offer a viable alternative to current cerebrospinal fluid and neuroimaging modalities. The current study aimed to replicate our earlier reports of altered binding within the AD-affected blood cellular fraction to copper-loaded immobilized metal affinity capture (IMAC) arrays. IMAC and anti-amyloid-β (Aβ) antibody arrays coupled with mass spectrometry were used to analyze blood samples collected from 218 participants from within the AIBL Study of Aging. Peripheral Aβ was fragile and prone to degradation in the AIBL samples, even when stored at -80°C. IMAC analysis of the AIBL samples lead to the isolation and identification of alpha-defensins 1 and 2 at elevated levels in the AD periphery, validating earlier findings. Alpha-defensins 1 and 2 were elevated in AD patients indicating that an inflammatory phenotype is present in the AD periphery; however, peripheral Aβ levels are required to supplement their prognostic power.
URI: https://ahro.austin.org.au/austinjspui/handle/1/12483
DOI: 10.3233/JAD-142286
Journal: Journal of Alzheimer's disease : JAD
URL: https://pubmed.ncbi.nlm.nih.gov/25408207
Type: Journal Article
Subjects: Alzheimer's disease
amyloid-β
biomarkers
blood
inflammation
mass spectrometry
α-defensins
Appears in Collections:Journal articles

Show full item record

Page view(s)

24
checked on Mar 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.